BMND — Biomind Labs Balance Sheet
0.000.00%
Last trade - 00:00- CA$27.54m
- CA$28.71m
Annual balance sheet for Biomind Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.27 | 0.026 | 0.024 | 0 | 0 |
| Net Total Receivables | 0.166 | — | — | — | — |
| Prepaid Expenses | |||||
| Total Current Assets | 2.44 | 0.045 | 0.045 | 0.021 | 0 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.088 | 0.044 | 0.029 | 0.02 | 0 |
| Total Assets | 2.53 | 0.089 | 0.074 | 0.041 | 0 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.325 | 0.337 | 1.51 | 1.34 | 1.74 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.335 | 0.337 | 1.51 | 1.34 | 1.74 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2.19 | -0.248 | -1.43 | -1.3 | -1.74 |
| Total Liabilities & Shareholders' Equity | 2.53 | 0.089 | 0.074 | 0.041 | 0 |
| Total Common Shares Outstanding |